Secondary Metabolites from Rosemary (Rosmarinus officinalis L.): Structure, Biochemistry and Therapeutic Implications Against Neurodegenerative Diseases



Rosemary (Rosmarinus officinalis L.), the representative of Lamiaceae family is known for its various medicinal uses that are accompanied by their hallmark secondary metabolites, i.e., carnosol, carnosic acid and rosmarinic acid (mostly the polyphenolic diterpenes). In the age of medicines and methodologies, when we are floating through the advancements and achievements, we are being hijacked by various diseases leading to increased number of young deaths. Neurological disorders are one of them and characterized by any impairment in the nervous system, brain or spinal cord. The majority of young and aged people around the globe are manifested by neurological disorders, i.e., stroke, epilepsy, dementia, Alzheimer’s disease (AD), Parkinson’s disease (PD) and migraine. A large number of therapeutic approaches mend the symptoms in early stages of these disorders, but with the span of time, patients become progressively more disabled as they may suffer from drug-associated adverse effects. Emphasizing on the urgent need of alternative therapeutic regimens, natural products are encouraged worldwide in terms of safety and to minimize the aforesaid loss. In this order, the current chapter summarizes the protective role of R. officinalis L. and its bio-active metabolites against various neurological disorders via targeting amyloid-beta (A-β) aggregation, neuronal cell death, acetylcholinesterase (AChE), neuroinflammation, β-secretase (BACE-1) activity, mitochondrial redox status, etc. Based on the multifunctional nature due to effective bio-active secondary metabolites, R. officinalis can be a terrific alternative therapeutic source against many neurodegenerative diseases.


Secondary metabolites Essential oils Neurological disorders Molecular markers 



We are highly indebted to Prof. S. W. Akhtar, chancellor, for providing us the state-of the-art research laboratory.


  1. Alkam T, Nitta A, Mizoguchi H, Itoh A, Nabeshima T (2007) A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by A beta (25–35). Behav Brain Res 180:139–145PubMedCrossRefPubMedCentralGoogle Scholar
  2. Al-Sereiti MR, Abu-Amer KM, Sen P (1999) Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37:124–130PubMedPubMedCentralGoogle Scholar
  3. Alvi SS, Ansari IA, Khan MS (2015) Pleiotropic role of lycopene in protecting various risk factors mediated atherosclerosis. Ann Phytomed 4:54–60Google Scholar
  4. Alvi SS, Iqbal D, Ahmad S, Khan MS (2016) Molecular rationale delineating the role of lycopene as a potent HMG-CoA reductase inhibitor: in vitro and in silico study. Nat Prod Res 30:2111–2114. Scholar
  5. Alvi SS, Ansari IA, Ahmad MK, Iqbal J, Khan MS (2017a) Lycopene amends LPS induced oxidative stress and hypertriglyceridemia via modulating PCSK-9 expression and Apo-CIII mediated lipoprotein lipase activity. Biomed Pharmacother 96:1082–1093PubMedCrossRefPubMedCentralGoogle Scholar
  6. Alvi SS, Ansari IA, Khan I, Iqbal J, Khan MS (2017b) Potential role of lycopene in targeting proprotein convertase subtilisin/kexin type-9 to combat hypercholesterolemia. Free Rad Biol Med 108:394–403CrossRefGoogle Scholar
  7. Aumeeruddy-Elalfi Z, Gurib-Fakim A, Mahomoodally MF (2015) Antimicrobial, antibiotic potentiating activity and phytochemical profile of essential oils from exotic and endemic medicinal plants of Mauritius. Ind Crop Prod 71:197–204CrossRefGoogle Scholar
  8. Aumeeruddy-Elalfi Z, Gurib-Fakim A, Mahomoodally MF (2016) Chemical composition, antimicrobial and antibiotic potentiating activity of essential oils from 10 tropical medicinal plants from Mauritius. J Herb Med 6:88–95CrossRefGoogle Scholar
  9. Azad N, Rasoolijazi H, Joghataie MT, Soleimani S (2011) Neuroprotective effects of carnosic acid in an experimental model of Alzheimer’s disease in rats. Cell J 13:39–44PubMedPubMedCentralGoogle Scholar
  10. Backhouse N, Rosales L, Apablaza C, Goïty L, Erazo S, Negrete R, Theodoluz C, Rodríguez J, Delporte C (2008) Analgesic, anti-inflammatory and antioxidant properties of Buddleja globosa, Buddlejaceae. J Ethnopharmacol 116:263–269PubMedCrossRefPubMedCentralGoogle Scholar
  11. Baig MH, Ahmad K, Rabbani G, Choi I (2018) Use of peptides for the management of Alzheimer’s disease: diagnosis and inhibition. Front Aging Neurosci 10:21. Scholar
  12. Bakirel T, Bakırel U, Keleş OÜ, Ülgen SG, Yardibi H (2008) In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J Ethnopharmacol 116:64–73PubMedCrossRefPubMedCentralGoogle Scholar
  13. Barbosa LN, da Silva PI, Andrade BF, Alves FC, Albano M, de Souza MD, Doyama JT, Rall VL, Júnior AF (2015) In vitro antibacterial and chemical properties of essential oils including native plants from Brazil against pathogenic and resistant bacteria. J Oleo Sci 64:289–298PubMedCrossRefPubMedCentralGoogle Scholar
  14. Barres BA, Barde Y (2000) Neuronal and glial cell biology. Curr Opin Neurobiol 10:642–648PubMedCrossRefPubMedCentralGoogle Scholar
  15. Barreto HM, Silva Filho EC, Lima ED, Coutinho HD, Morais-Braga MF, Tavares CC, Tintino SR, Rego JV, de Abreu AP, Lustosa MD, Oliveira RW (2014) Chemical composition and possible use as adjuvant of the antibiotic therapy of the essential oil of Rosmarinus officinalis L. Ind Crops Prod 59:290–294CrossRefGoogle Scholar
  16. Begum A, Sandhya S, Ali SS, Vinod KR, Reddy S, Banji D (2013) An in-depth review on the medicinal flora Rosmarinus officinalis (Lamiaceae). Acta Sci Pol Technol Aliment 12:61–73PubMedPubMedCentralGoogle Scholar
  17. Benincá JP, Dalmarco JB, Pizzolatti MG, Fröde TS (2011) Analysis of the anti-inflammatory properties of Rosmarinus officinalis L. in mice. Food Chem 124:468–475CrossRefGoogle Scholar
  18. Bernardes WA, Lucarini R, Tozatti MG, Souza MG, Andrade Silva ML, da Silva Filho AA, Martins CH, Miller Crotti AE, Pauletti PM, Groppo M, Cunha WR (2010) Antimicrobial activity of Rosmarinus officinalis against oral pathogens: relevance of carnosic acid and carnosol. Chem Biodivers 7:1835–1840PubMedCrossRefPubMedCentralGoogle Scholar
  19. Borrás LI, Arráez-Román D, Herrero M, Ibáñez E, Segura-Carretero A, Fernández-Gutiérrez A (2011) Comparison of different extraction procedures for the comprehensive characterization of bioactive phenolic compounds in Rosmarinus officinalis by reversed-phase high-performance liquid chromatography with diode array detection coupled to electrospray time. J Chromatogr A 1218:7682–7690CrossRefGoogle Scholar
  20. Bozin B, Mimica-Dukic N, Samojlik I, Jovin E (2007) Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem 55:7879–7885PubMedCrossRefPubMedCentralGoogle Scholar
  21. Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27:325–355PubMedCrossRefPubMedCentralGoogle Scholar
  22. Chen JH, Ou HP, Lin CY, Lin FJ, Wu CR, Chang SW, Tsai CW (2012) Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chem Res Toxicol 25:1893–1901PubMedCrossRefPubMedCentralGoogle Scholar
  23. Chen WW, Zhang X, Huang WJ (2016) Role of neuroinflammation in neurodegenerative diseases. Mol Med Rep 13:3391–3396PubMedPubMedCentralCrossRefGoogle Scholar
  24. Cheng YS, Liao TY, Lin C, Shen HC, Wang YH, Chang CW, Liu RS, Chen RP, Tu PH (2017) An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice. EMBO Mol Med 9:703–715PubMedPubMedCentralCrossRefGoogle Scholar
  25. Choi HR, Choi JS, Han YN, Bae SJ, Chung HY (2002) Peroxynitrite scavenging activity of herb extracts. Phytother Res 16:364–367PubMedCrossRefPubMedCentralGoogle Scholar
  26. Chovatiya R, Medzhitov R (2014) Stress, inflammation, and defense of homeostasis. Mol Cell 54:281–288PubMedPubMedCentralCrossRefGoogle Scholar
  27. da Rosa JS, Facchin BM, Bastos J, Siqueira MA, Micke GA, Dalmarco EM, Pizzolatti MG, Fröde TS (2013) Systemic administration of Rosmarinus officinalis attenuates the inflammatory response induced by carrageenan in the mouse model of pleurisy. Planta Med 79:1605–1614PubMedCrossRefPubMedCentralGoogle Scholar
  28. de Oliveira MR (2015) The dietary components carnosic acid and carnosol as neuroprotective agents: a mechanistic view. Mol Neurobiol 53:6155–6168PubMedCrossRefPubMedCentralGoogle Scholar
  29. Del Baño MJ, Benavente-García O, Lorente J, Martín-Gil R, Acevedo C, Alcaraz M (2006) Radioprotective−antimutagenic effects of rosemary phenolics against chromosomal damage induced in human lymphocytes by γ-rays. J Agric Food Chem 54:2064–2068PubMedCrossRefPubMedCentralGoogle Scholar
  30. Doolaege EH, Raes K, De Vos F, Verhé R, De Smet S (2011) Absorption, distribution and elimination of carnosic acid, a natural antioxidant from Rosmarinus officinalis, in rats. Plant Foods Hum Nutr 66:196–202PubMedCrossRefGoogle Scholar
  31. Doughari JH (2012) Phytochemicals: extraction methods, basic structures and mode of action as potential chemotherapeutic agents. In: Rao V (ed) Phytochemicals – a global perspective of their role in nutrition and health. InTech, Rijeka, pp 1–32Google Scholar
  32. Drachman DA (2014) The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimer’s disease. Alzheimers Dement 10:372–380PubMedCrossRefGoogle Scholar
  33. Faixová Z, Faix S (2008) Biological effects of rosemary (Rosmarinus officinalis L.) essential oil. Folia Vet 52:135–139Google Scholar
  34. Felicidade I, Lima JD, Pesarini JR, Monreal AC, Mantovani MS, Ribeiro LR, Oliveira RJ (2014) Mutagenic and antimutagenic effects of aqueous extract of rosemary (Rosmarinus officinalis L.) on meristematic cells of Allium cepa. Genet Mol Res 13:9986–9996PubMedCrossRefGoogle Scholar
  35. Funke SA, Willbold D (2012) Peptides for therapy and diagnosis of Alzheimer’s disease. Curr Pharm Des 18:755–767PubMedPubMedCentralCrossRefGoogle Scholar
  36. Genova ML, Bianchi C, Lenaz G (2005) Supercomplex organization of the mitochondrial respiratory chain and the role of the coenzyme Q pool: pathophysiological implications. Biofactors 25:5–20PubMedCrossRefGoogle Scholar
  37. González-Vallinas M, Molina S, Vicente G, de la Cueva A, Vargas T, Santoyo S, García-Risco MR, Fornari T, Reglero G, de Molina AR (2013) Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol Res 72:61–68PubMedCrossRefGoogle Scholar
  38. González-Vallinas M, Molina S, Vicente G, Zarza V, Martín-Hernández R, García-Risco MR, Fornari T, Reglero G, De Molina AR (2014) Expression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of rosemary diterpenes in colon and pancreatic cancer. PLoS One 9:e98556. Scholar
  39. González-Vallinas M, Reglero G, Ramírez de Molina A (2015) Rosemary (Rosmarinus officinalis L.) extract as a potential complementary agent in anticancer therapy. J Nutr Cancer 67:1221–1229Google Scholar
  40. Gouveia AR, Alves M, Silva JA, Saraiva C (2016) The antimicrobial effect of rosemary and thyme essential oils against Listeria monocytogenes in sous vide cook-chill beef during storage. Procedia Food Sci 7:173–176CrossRefGoogle Scholar
  41. Grundman M, Dibernardo A, Raghavan N, Krams M, Yuen E (2013) 2012: a watershed year for Alzheimer’s disease research. J Nutr Health Aging 17:51–53PubMedCrossRefGoogle Scholar
  42. Gutiérrez R, Alvarado JL, Presno M, Pérez-Veyna O, Serrano CJ, Yahuaca P (2010) Oxidative stress modulation by Rosmarinus officinalis in CCl4-induced liver cirrhosis. Phytother Res 24:595–601PubMedCrossRefGoogle Scholar
  43. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid b-peptide. Nat Rev Mol Cell Biol 8:101–112PubMedCrossRefGoogle Scholar
  44. Habtemariam S (2016) The therapeutic potential of rosemary (Rosmarinus officinalis) diterpenes for Alzheimer’s disease. Evid-Based Complement Alternat Med 2016:2680409. Scholar
  45. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674PubMedCrossRefGoogle Scholar
  46. Haraguchi H, Saito T, Okamura N, Yagi A (1995) Inhibition of lipid peroxidation and superoxide generation by diterpenoids from Rosmarinus officinalis. Planta Med 61:333–336PubMedCrossRefGoogle Scholar
  47. Harkat-Madouri L, Asma B, Madani K, Said ZB, Rigou P, Grenier D, Allalou H, Remini H, Adjaoud A, Boulekbache-Makhlouf L (2015) Chemical composition, antibacterial and antioxidant activities of essential oil of Eucalyptus globulus from Algeria. Ind Crops Prod 78:148–153CrossRefGoogle Scholar
  48. Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M, Roiser JP, Neumeister A, Meyers N, Charney DS, Drevets WC (2008) Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 65:521–531PubMedPubMedCentralCrossRefGoogle Scholar
  49. Herrup K (2015) The case for rejecting the amyloid cascade hypothesis. Nat Neurosci 18:794–799PubMedCrossRefGoogle Scholar
  50. Hou CW, Lin YT, Chen YL, Wang YH, Chou JL, Ping LY, Jeng KC (2012) Neuroprotective effects of carnosic acid on neuronal cells under ischemic and hypoxic stress. Nutr Neurosci 15(6):257–263PubMedCrossRefPubMedCentralGoogle Scholar
  51. Hu X, Weng Z, Chu CT, Zhang L, Cao G, Gao Y, Signore A, Zhu J, Hastings T, Greenamyre JT, Chen J (2011) Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci 31:247–261PubMedPubMedCentralCrossRefGoogle Scholar
  52. Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K, Ma W, Georgiadis C, Laskin JD, Conney AH (1994) Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 54:701–708PubMedPubMedCentralGoogle Scholar
  53. Hussain AI, Anwar F, Chatha SA, Jabbar A, Mahboob S, Nigam PS (2010) Rosmarinus officinalis essential oil: antiproliferative, antioxidant and antibacterial activities: Braz. J Microbiol 41:1070–1078Google Scholar
  54. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the aminoterminal Neh2 domain. Genes Dev 13:76–86PubMedPubMedCentralCrossRefGoogle Scholar
  55. Jarrott B, Williams SJ (2015) Chronic brain inflammation: the neurochemical basis for drugs to reduce inflammation. Neurochem Res 41:523–533PubMedCrossRefGoogle Scholar
  56. Jia Z, Misra BR, Zhu H, Li Y, Misra HP (2009) Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity. Neurotoxicology 30:1–9PubMedCrossRefGoogle Scholar
  57. Jiang J, Borisenko GG, Osipov A, Martin I, Chen R, Shvedova AA, Sorokin A, Tyurina YY, Potapovich A, Tyurin VA, Graham SH (2004) Arachidonic acid-induced carbon-centered radicals and phospholipid peroxidation in cyclo-oxygenase-2-transfected PC12 cells. J Neurochem 90:1036–1049PubMedCrossRefGoogle Scholar
  58. Jindal A, Soyal D, Sancheti G, Goyal PK (2006) Radioprotective potential of Rosemarinus officinalis against lethal effects of gamma radiation: a preliminary study. J Environ Pathol Toxicol Oncol 25:633–642PubMedCrossRefGoogle Scholar
  59. Jordán MJ, Lax V, Rota MC, Lorán S, Sotomayor JA (2012) Relevance of carnosic acid, carnosol, and rosmarinic acid concentrations in the in vitro antioxidant and antimicrobial activities of Rosmarinus officinalis (L.) methanolic extracts. J Agric Food Chem 60:9603–9608PubMedCrossRefGoogle Scholar
  60. Kar S, Palit S, Ball WB, Das PK (2012) Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis 17:735–747PubMedCrossRefPubMedCentralGoogle Scholar
  61. Khan I, Ahmad W, Karim N, Ahmad M, Khan M, Tariq SA, Sultana N, Shah R, Khan A, Abdelhalim A (2016) Antidiabetic activity and histopathological analysis of carnosol isolated from Artemisia indica Linn. in streptozotocin-induced diabetic rats. Med Chem Res 26:335–343CrossRefGoogle Scholar
  62. Kim HG, Ju MS, Kim DH, Hong J, Cho SH, Cho KH, Park W, Lee EH, Kim SY, Oh MS (2010a) Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson’s disease. Basic Clin Pharmacol Toxicol 107:958–964PubMedCrossRefPubMedCentralGoogle Scholar
  63. Kim SY, Park E, Park JA, Choi BS, Kim S, Jeong G, Kim CS, Kim DK, Kim SJ, Chun HS (2010b) The plant phenolic diterpene carnosol suppresses sodium nitroprusside-induced toxicity in C6 glial cells. J Agric Food Chem 58:1543–1550PubMedCrossRefPubMedCentralGoogle Scholar
  64. Kosaka K, Yokoi T (2003) Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98G human glioblastoma cells. Biol Pharm Bull 26:1620–1622PubMedCrossRefPubMedCentralGoogle Scholar
  65. Kwon SH, Lee HK, Kim JA, Hong SI, Kim HC, Jo TH, Park YI, Lee CK, Kim YB, Lee SY, Jang CG (2010) Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via antiacetylcholinesterase and anti-oxidative activities in mice. Eur J Pharmacol 649:210–217PubMedCrossRefPubMedCentralGoogle Scholar
  66. Lee CH, Hwang DS, Kim HG, Oh H, Park H, Cho JH, Lee JM, Jang JB, Lee KS, Oh MS (2010) Protective effect of Cyperi rhizoma against 6-hydroxydopamine-induced neuronal damage. J Med Food 13:564–571PubMedCrossRefPubMedCentralGoogle Scholar
  67. Li XL, Liu JX, Li P, Zheng YQ (2014) Protective effect of rosmarinic acid on hypoxia/reoxygenation injury in cardiomyocytes. China J Chinese Materia Med 39:1897–1901Google Scholar
  68. Li H, Chen C, Cao X (2015) Essential oils-oriented chiral esters as potential pesticides: asymmetric syntheses, characterization and bio-evolution. Ind Crops Prod 76:432–436CrossRefGoogle Scholar
  69. Li CZ, Grajales S, Shuang S, Dong C, Nair M (2017) b-amyloid biomarker detection for Alzheimer’s disease. J Anal Test 1:15. Scholar
  70. Lo AH, Liang YC, Lin-Shiau SY, Ho CT, Lin JK (2002) Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages. Carcinogenesis 23:983–991PubMedCrossRefGoogle Scholar
  71. Lovkova MY, Buzuk GN, Sokolova SM, Kliment’eva NI (2001) Chemical features of medicinal plants. Appl Biochem Microbiol 37:229–237CrossRefGoogle Scholar
  72. Lu SC (2013) Glutathione synthesis. Biochim Biophys Acta 1830:3143–3153PubMedCrossRefPubMedCentralGoogle Scholar
  73. Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M (2012) New drug targets in depression: inflammatory, cell mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf-2 activators and GSK-3 inhibitors. Inflammopharmacology 20:127–150PubMedCrossRefPubMedCentralGoogle Scholar
  74. Makino T, Ono T, Liu N, Nakamura T, Muso E, Honda G (2002) Suppressive effects of rosmarinic acid on mesangio proliferative glomerulonephritis in rats. Nephron 92:898–904PubMedCrossRefPubMedCentralGoogle Scholar
  75. Mangoura D, Sakellaridis N, Jones J, Vernadakis A (1989) Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture. Neurochem Res 14:941–947PubMedCrossRefPubMedCentralGoogle Scholar
  76. Manoharan S, VasanthaSelvan M, Silvan S, Baskaran N, Singh AK, Kumar VV (2010) Carnosic acid: a potent chemopreventive agent against oral carcinogenesis. Chem Biol Interact 188:616–622PubMedCrossRefPubMedCentralGoogle Scholar
  77. Martin HL, Teismann P (2009) Glutathione: a review on its role and significance in Parkinson’s disease. FASEB J 23:3263–3272PubMedCrossRefPubMedCentralGoogle Scholar
  78. Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, de Galarreta CM, Cuadrado A (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279:8919–8929PubMedCrossRefPubMedCentralGoogle Scholar
  79. Mattson MP, Cheng A (2006) Neurohormetic phytochemicals: low dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 29:632–639PubMedCrossRefPubMedCentralGoogle Scholar
  80. Mena NP, Urrutia PJ, Lourido F, Carrasco CM, Núñez MT (2015) Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. Mitochondrion 21:92–105PubMedCrossRefPubMedCentralGoogle Scholar
  81. Menting KW, Claassen JAHR (2014) β-Secretase inhibitor; a promising novel therapeutic drug in Alzheimer’s disease. Front Aging Neurosci 6:165. Scholar
  82. Miller DM, Singh IN, Wang JA, Hall ED (2013) Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic Biol Med 57:1–9. Scholar
  83. Miraj S (2016) An evidence-based review on herbal remedies of Rosmarinus officinalis. Der Pharma Lett 8:426–436Google Scholar
  84. Moi P, Chan K, Asunis I, Cao A, Kan YW (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A 91:9926–9930PubMedPubMedCentralCrossRefGoogle Scholar
  85. Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G (2010) Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochim Biophys Acta 1802:2–10PubMedCrossRefPubMedCentralGoogle Scholar
  86. Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, Maes M (2014) The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol 50:1059–1084PubMedCrossRefPubMedCentralGoogle Scholar
  87. Naemura A, Ura M, Yamashita T, Arai R, Yamamoto J (2008) Long-term intake of rosemary and common thyme herbs inhibits experimental thrombosis without prolongation of bleeding time. Thromb Res 122:517–522PubMedCrossRefPubMedCentralGoogle Scholar
  88. Naoi M, Maruyama W, Shamoto-Nagai M, Yi H, Akao Y, Tanaka M (2005) Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol 31:81–93PubMedCrossRefPubMedCentralGoogle Scholar
  89. Nobile V, Michelotti A, Cestone E, Caturla N, Castillo J, Benavente-García O, Pérez-Sánchez A, Micol V (2016) Skin photoprotective and antiageing effects of a combination of rosemary (Rosmarinus officinalis) and grapefruit (Citrus paradisi) polyphenols. Food Nutr Res 60:31871. Scholar
  90. Orhan I, Aslan S, Kartal M, Şener B, Başer KH (2008) Inhibitory effect of Turkish Rosmarinus officinalis L. on acetylcholinesterase and butyrylcholinesterase enzymes. Food Chem 108:663–668PubMedCrossRefPubMedCentralGoogle Scholar
  91. Ozarowski M, Mikolajczak PL, Bogacz A, Gryszczynska A, Kujawska M, Jodynis-Liebert J, Piasecka A, Napieczynska H, Szulc M, Kujawski R, Bartkowiak-Wieczorek J (2013) Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain. Fitoterapia 91:261–271PubMedCrossRefPubMedCentralGoogle Scholar
  92. Papa S, Martino PL, Capitanio G, Gaballo A, De Rasmo D, Signorile A, Petruzzella V (2012) The oxidative phosphorylation system in mammalian mitochondria. Adv Exp Med Biol 942:3–37PubMedCrossRefPubMedCentralGoogle Scholar
  93. Park JA, Kim S, Lee SY, Kim CS, Kim DK, Kim SJ, Chun HS (2008) Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. Neuroreport 19:1301–1304PubMedCrossRefPubMedCentralGoogle Scholar
  94. Park SE, Kim S, Sapkota K, Kim SJ (2010) Neuroprotective effect of Rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y. Cell Mol Neurobiol 30:759–767PubMedCrossRefPubMedCentralGoogle Scholar
  95. Peng CH, Su JD, Chyau CC, Sung TY, Ho SS, Peng CC, Peng RY (2007) Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. Biosci Biotechnol Biochem 71:2223–2232PubMedCrossRefPubMedCentralGoogle Scholar
  96. Perez-Fons L, GarzÓn MT, Micol V (2010) Relationship between the antioxidant capacity and effect of rosemary (Rosmarinus officinalis L.) polyphenols on membrane phospholipid order. J Agric Food Chem 58:161–171PubMedCrossRefPubMedCentralGoogle Scholar
  97. Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK (2000) In vitro inhibition of erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 52:895–902PubMedCrossRefPubMedCentralGoogle Scholar
  98. Perry NS, Bollen C, Perry EK, Ballard C (2003) Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 75:651–659PubMedCrossRefPubMedCentralGoogle Scholar
  99. Petiwala SM, Johnson JJ (2015) Diterpenes from rosemary (Rosmarinus officinalis): defining their potential for anti-cancer activity. Cancer Lett 367:93–102PubMedCrossRefPubMedCentralGoogle Scholar
  100. Posadas SJ, Caz V, Largo C, De la Gandara B, Matallanas B, Reglero G, De Miguel E (2009) Protective effect of supercritical fluid rosemary extract, Rosmarinus officinalis, on antioxidants of major organs of aged rats. Exp Gerontol 44:383–389PubMedCrossRefPubMedCentralGoogle Scholar
  101. Pun PB, Lu J, Kan EM, Moochhala S (2010) Gases in the mitochondria. Mitochondrion 10:83–93PubMedCrossRefPubMedCentralGoogle Scholar
  102. Qiao S, Li W, Tsubouchi R, Haneda M, Murakami K, Takeuchi F, Nisimoto Y, Yoshino M (2005) Rosmarinic acid inhibits the formation of reactive oxygen and nitrogen species in RAW264.7 macrophages. Free Rad Res 39:995–1003CrossRefGoogle Scholar
  103. Rahimifard M, Navaei-Nigjeh M, Mahroui N, Mirzaei S, Siahpoosh Z (2014) Improvement in the function of isolated rat pancreatic islets through reduction of oxidative stress using traditional Iranian medicine. Cell J 16:147–163PubMedPubMedCentralGoogle Scholar
  104. Raschetti R, Albanese E, Vanacore N, Maggini M (2007) Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med 4:1818–1828CrossRefGoogle Scholar
  105. Rašković A, Milanović I, Pavlović N, Ćebović T, Vukmirović S, Mikov M (2014) Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC Compl Altern Med 14:225. Scholar
  106. Samuelsson G, Bohlin L (2001) Drugs of natural origin: a treatise of pharmacognosy, 6th edn. Swedish Pharmaceutical Press, StockholmGoogle Scholar
  107. Santos FA, Rao VSN (2000) Antiinflammatory and antinociceptive effects of 1,8-cineole a terpenoid oxide present in many plant essential oils. Phytother Res 14:240–244PubMedCrossRefPubMedCentralGoogle Scholar
  108. Santoyo S, Cavero S, Jaime L, Ibanez E, Senorans FJ, Reglero G (2005) Chemical composition and antimicrobial activity of Rosmarinus officinalis L. essential oil obtained via supercritical fluid extraction. J Food Prot 68:790–795PubMedCrossRefPubMedCentralGoogle Scholar
  109. Satoh T, Kosaka K, Itoh K, Kobayashi A, Yamamoto M, Shimojo Y, Kitajima C, Cui J, Kamins J, Okamoto SI, Izumi M (2008a) Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem 104:1116–1131PubMedCrossRefPubMedCentralGoogle Scholar
  110. Satoh T, Izumi M, Inukai Y, Tsutsumi Y, Nakayama N, Kosaka K, Shimojo Y, Kitajima C, Itoh K, Yokoi T, Shirasawa T (2008b) Carnosic acid protects neuronal HT22 cells through activation of the antioxidant-responsive element in free carboxylic acid- and catechol hydroxyl moieties-dependent manners. Neurosci Lett 434:260–265PubMedCrossRefPubMedCentralGoogle Scholar
  111. Satoh T, McKercher SR, Lipton SA (2013) Nrf2/ARE mediated antioxidant actions of pro-electrophilic drugs. Free Rad Biol Med 65:645–657PubMedCrossRefPubMedCentralGoogle Scholar
  112. Satyal P, Jones TH, Lopez EM, McFeeters RL, Ali NA, Mansi I, Al-kaf AG, Setzer WN (2017) Chemotypic characterization and biological activity of Rosmarinus officinalis. Foods 6:20. Scholar
  113. Savelev S, Okello E, Perry NS, Wilkins RM, Perry EK (2003) Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil. Pharma Biochem Behav 75:661–668CrossRefGoogle Scholar
  114. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM (2008) Amyloid-ß protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842PubMedPubMedCentralCrossRefGoogle Scholar
  115. Shimojo Y, Kosaka K, Noda Y, Shimizu T, Shirasawa T (2010) Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis. J Neurosci Res 88:896–904PubMedPubMedCentralGoogle Scholar
  116. Sies H (2015) Oxidative stress: a concept in redox biology and medicine. Redox Biol 4:180–183PubMedPubMedCentralCrossRefGoogle Scholar
  117. Song JX, Shaw PC, Sze CW, Tong Y, Yao XS, Ng TB, Zhang YB (2010) Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-kappaB modulation. Neurochem Int 57:676–689PubMedCrossRefPubMedCentralGoogle Scholar
  118. Sotelo-Félix JI, Martinez-Fong D, De la Torre PM (2002) Protective effect of carnosol on CCl4-induced acute liver damage in rats. Eur J Gastroenterol Hepatol 14:1001–1006PubMedCrossRefPubMedCentralGoogle Scholar
  119. Soyal D, Jindal A, Singh I, Goyal PK (2007) Protective capacity of rosemary extract against radiation induced hepatic injury in mice. Iran J Radiat Res 4:161–168Google Scholar
  120. Sperner-Unterweger B, Kohl C, Fuchs D (2014) Immune changes and neurotransmitters: possible interactions in depression. Prog Neuropsy Biol Psychiat 48:268–276CrossRefGoogle Scholar
  121. Stephenson J, Nutma E, van der Valk P, Amor S (2018) Inflammation in CNS neurodegenerative diseases. Immunology 154:204–219PubMedPubMedCentralCrossRefGoogle Scholar
  122. Takaki I, Bersani-Amado LE, Vendruscolo A, Sartoretto SM, Diniz SP, Bersani-Amado CA, Cuman RK (2008) Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Med Food 11:741–746PubMedCrossRefPubMedCentralGoogle Scholar
  123. Tamaki Y, Tabuchi T, Takahashi T, Kosaka K, Satoh T (2010) Activated glutathione metabolism participates in protective effects of carnosic acid against oxidative stress in neuronal HT22 cells. Planta Med 76:683–688PubMedCrossRefPubMedCentralGoogle Scholar
  124. Teixeira B, Marques A, Ramos C, Serrano C, Matos O, Neng NR, Nogueira JM, Saraiva JA, Nunes ML (2013) Chemical composition and bioactivity of different oregano (Origanum vulgare) extracts and essential oil. J Sci Food Agric 93:2707–2714PubMedCrossRefPubMedCentralGoogle Scholar
  125. Tian LL, Zhou Z, Zhang Q, Sun YN, Li CR, Cheng CH, Zhong ZY, Wang SQ (2007) Protective effect of (±) isoborneol against 6-OHDA-induced apoptosis in SH-SY5Y cells. Cell Physiol Biochem 20:1019–1032PubMedCrossRefPubMedCentralGoogle Scholar
  126. Tu Z, Moss-Pierce T, Ford P et al (2013) Rosemary (Rosmarinus officinalis L.) extract regulates glucose and lipid metabolism by activating AMPK and PPAR pathways in HepG2 cells. J Agric Food Chem 61:2803–2810PubMedCrossRefPubMedCentralGoogle Scholar
  127. Ulbricht C, Abrams TR, Brigham A, Ceurvels J, Clubb J, Curtiss W, Kirkwood CD, Giese N, Hoehn K, Iovin R, Isaac R (2010) An evidence-based systematic review of rosemary (Rosmarinus officinalis) by the Natural Standard Research Collaboration. J Diet Suppl 7:351–413PubMedCrossRefPubMedCentralGoogle Scholar
  128. Vali S, Mythri RB, Jagatha B, Padiadpu J, Ramanujan KS, Andersen JK, Gorin F, Bharath MM (2007) Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson’s disease: a dynamic model. Neuroscience 149:917–930PubMedCrossRefPubMedCentralGoogle Scholar
  129. Van Itallie TB (2015) Biomarkers, ketone bodies and the prevention of Alzheimer’s disease. Metabolism 64:S51–S57CrossRefGoogle Scholar
  130. Vaquero MR, Garcia Villalba R, Larrosa M, Yáñez-Gascón MJ, Fromentin E, Flanagan J, Roller M, Tomás-Barberán FA, Espín JC, García-Conesa MT (2013) Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats. Mol Nutr Food Res 57:1834–1846Google Scholar
  131. Venditti P, Di Stefano L, Di Meo S (2013) Mitochondrial metabolism of reactive oxygen species. Mitochondrion 13:71–82. Scholar
  132. Verma R, Nehru B (2009) Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson’s disease. Neurochem Int 55:369–375PubMedCrossRefPubMedCentralGoogle Scholar
  133. Vigé X, Costa E, Wise BC (1991) Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes. Mol Pharmacol 40:186–192PubMedPubMedCentralGoogle Scholar
  134. Villareal MO, Ikeya A, Sasaki K, Arfa AB, Neffati M, Isoda H (2017) Anti-stress and neuronal cell differentiation induction effects of Rosmarinus officinalis L. essential oil. BMC Compl Altern Med 17:549. Scholar
  135. Viuda-Martos M, El Gendy A-N, Sendra E et al (2010a) Chemical composition and antioxidant and antilisteria activities of essential oils obtained from some egyptian plants. J Agric Food Chem 58:9063–9070PubMedCrossRefGoogle Scholar
  136. Viuda-Martos M, Ruiz Navajas Y, Sánchez Zapata E, Fernández-López J, Pérez-Álvarez JA (2010b) Antioxidant activity of essential oils of five spice plants widely used in a Mediterranean diet. Flavour Frag J 25:13–19CrossRefGoogle Scholar
  137. Wang X, Su B, Zheng L, Perry G, Smith MA, Zhu X (2009) The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J Neurochem 109:S153–S159CrossRefGoogle Scholar
  138. Wang W, Li N, Luo M, Zu Y, Efferth T (2012) Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules 17:2704–2713PubMedPubMedCentralCrossRefGoogle Scholar
  139. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239PubMedCrossRefPubMedCentralGoogle Scholar
  140. Wilkins HM, Swerdlow RH (2016) Relationships between mitochondria and neuroinflammation: implications for Alzheimer’s disease. Curr Top Med Chem 16:849–857PubMedPubMedCentralCrossRefGoogle Scholar
  141. Wilmo AP, Martin P (2010) World Alzheimer report 2010. The global economic impact of dementia. Alzheimer’s Disease International, LondonGoogle Scholar
  142. Wortmann M (2012) Dementia: a global health priority-highlights from an ADI and World Health Organization report. Alzheimer’s Res Ther 4:40. Scholar
  143. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134:489–492PubMedCrossRefPubMedCentralGoogle Scholar
  144. Xiang Q, Ma Y, Dong J, Shen R (2014) Carnosic acid induces apoptosis associated with mitochondrial dysfunction and Akt inactivation in HepG2 cells. Int J Food Sci Nutr 7486:76–84Google Scholar
  145. Yamamoto J, Yamada K, Naemura A, Yamashita T, Arai R (2005) Testing various herbs for antithrombotic effect. Nutrition 21:580–587PubMedCrossRefPubMedCentralGoogle Scholar
  146. Yanagitai M, Itoh S, Kitagawa T, Takenouchi T, Kitani H, Satoh T (2012) Carnosic acid, a pro-electrophilic compound, inhibits LPS-induced activation of microglia. Biochem Biophys Res Commun 418:22–26PubMedCrossRefPubMedCentralGoogle Scholar
  147. Yoshida H, Meng P, Matsumiya T, Tanji K, Hayakari R, Xing F, Wang L, Tsuruga K, Tanaka H, Mimura J, Kosaka K (2014) Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells. Neurosci Res 79:83–93PubMedCrossRefPubMedCentralGoogle Scholar
  148. Yu MH, Choi JH, Chae IG, Im HG, Yang SA, More K, Lee IS, Lee J (2012) Suppression of LPS-induced inflammatory activities by Rosmarinus officinalis L. Food Chem 136:1047–1054PubMedCrossRefPubMedCentralGoogle Scholar
  149. Zanella CA, Treichel H, Cansian RL, Roman SS (2012) The effects of acute administration of the hydroalcoholic extract of rosemary (Rosmarinus officinalis L.) (Lamiaceae) in animal models of memory. Braz J Pharm Sci 48:389–397CrossRefGoogle Scholar
  150. Zhang Y, Adelakun TA, Qu L, Li X, Li J, Han L, Wang T (2014) New terpenoid glycosides obtained from Rosmarinus officinalis L. aerial parts. Fitoterapia 99:78–85PubMedCrossRefPubMedCentralGoogle Scholar
  151. Zhang D, Lee B, Nutter A, Song P, Dolatabadi N, Parker J, Sanz-Blasco S, Newmeyer T, Ambasudhan R, McKercher SR, Masliah E (2015) Protection of cyanide-induced brain injury by the Nrf2 transcriptional activator carnosic acid. J Neurochem 133:898–908PubMedPubMedCentralCrossRefGoogle Scholar
  152. Zhou X, Hollern D, Liao J, Andrechek E, Wang H (2013) NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors. Cell Death Dis 4:e560. Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.IIRC-5, Clinical Biochemistry and Natural Product Research Lab, Department of BiosciencesIntegral UniversityLucknowIndia
  2. 2.Faculty of Natural Sciences, Department of BiosciencesJamia Millia Islamia UniversityNew DelhiIndia
  3. 3.Department of Medical Laboratory SciencesCollege of Applied medical Sciences, Majmaah UniversityAl-MajmaahSaudi Arabia

Personalised recommendations